Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.50NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1575.86US
B.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.50NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-1981.37China
B.1.494NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.494NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.494NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.167NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.167NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.167NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.267NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.267NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.267NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.165NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
B.1.165NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.165NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
B.1.554NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.554NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.554NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.243.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.243.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.243.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.2.5.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.2.5.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2.5.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.450NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.450NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.450NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.130NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.130NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.130NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.444NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
B.1.444NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.444NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
AW.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AW.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.268NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.268NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.268NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.344NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.344NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.344NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.103NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.103NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.103NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.485NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.485NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.485NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.119NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.119NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used